2m 2m 2m 2m 2m 2m 2m
Novartis Sp ADR (NVS)
NYSE
$154.00-$0.05 (-0.03%)
Price as of Jul 13, 2026 6:59 PM EDT- $293.9BMarket Cap
- 31.14%1-Year Change
- Drug Manufacturers - GeneralIndustry
Novartis Sp ADR (NVS)
$154.00-$0.05 (-0.03%)
NVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $154.05 | ||
Change | -$0.57 (-0.37%) | ||
Open | $154.80 | ||
High | $155.00 | ||
Low | $153.63 | ||
Previous Close | $154.62 | ||
Volume | 1,165,696 | ||
30-Day Average Volume | 2,173,813 | ||
1-Week Change | -3.66% | ||
1-Month Change | 4.00% | ||
1-Year Change | 31.14% | ||
3-Year Change | 76.94% | ||
5-Year Change | 100.26% | ||
Fundamentals | |||
Shares Outstanding | 1.9B | ||
Total Assets | $110.9B | ||
Market Cap | $293.9B | ||
Enterprise Value | $283.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 21.54% | ||
Trailing Annual Dividend Yield | 3.08% | ||
Ex-Dividend Date | 03/11/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield